Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 34, Issue 49, 2016, Pages 6102-6109

  Kerr, Robbie ^a   Eckert, Linda O ^b   Winikoff, Beverly ^c   Durocher, Jill ^c   Meher, Shireen ^a   Fawcus, Sue ^d   Mundle, Shuchita ^e   Mol, Ben ^f   Arulkumaran, Sabaratnam ^g   Khan, Khalid ^h   Wandwabwa, Julius ⁱ   Kochhar, Sonali ^j   Weeks, Andrew ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GYNUITY HEALTH PROJECTS   (United States)

^d Mowbray Maternity Hospital   (South Africa)

^e Government Medical College and Hospital Nagpur   (India)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ BUSITEMA UNIVERSITY   (Uganda)

^j Healthcare Management Consultants   (India)

more..

Author keywords

Adverse event; Case definition; Guidelines; Immunization; Postpartum haemorrhage

Indexed keywords

HEMOGLOBIN; VACCINE;

ARTICLE; CLINICAL OUTCOME; DRUG SAFETY; FEMALE; HEMATOCRIT; HUMAN; IMMUNIZATION; INFORMATION PROCESSING; LABORATORY TEST; MEDICAL HISTORY; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; VITAL SIGN; DRUG SURVEILLANCE PROGRAM; PREGNANCY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNIZATION; POSTPARTUM HEMORRHAGE; PREGNANCY; VACCINES;

EID: 84999652006     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.039     Document Type: Article

References (39)

1. [1] Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.-B., Daniels, J., et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health 2 (2014), e323–e333.
2. [2] Carroli, G., Cuesta, C., Abalos, E., Gulmezoglu, A.M., Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 22 (2008), 999–1012.
3. [3] RCOG, RCOG Green-top Guideline No 52: prevention and management of postpartum haemorrhage. 2009 updated 2011.
4. [4] Bose, P., Regan, F., Paterson-Brown, S., Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG: Int J Obstet Gynaecol 113 (2006), 919–924.
5. [5] Stafford, I., Dildy, G.A., Clark, S.L., Belfort, M.A., Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 199 (2008), 519.e1–519.e7.
6. [6] Schorn, M.N., Measurement of blood loss: review of the literature. J Midwifery Women's Health 55 (2010), 20–27.
7. [7] Patel, A., Goudar, S.S., Geller, S.E., Kodkany, B.S., Edlavitch, S.A., Wagh, K., et al. Drape estimation vs. visual assessment for estimating postpartum haemorrhage. Int J Gynecol Obstet 93 (2006), 220–224.
8. [8] Zhang, W.H., Deneux-Tharaux, C., Brocklehurst, P., Juszczak, E., Joslin, M., Alexander, S., Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries. BMJ 340 (2010), c293–c300.
9. [9] Organisation WH, The prevention and management of postpartum haemorrhage: report of a technical working group, Geneva 3–6 July 1989. 1990.
10. [10] Menard, M.K., Main, E.K., Currigan, S.M., Executive summary of the reVITALize initiative. Obstet Gynecol 124 (2014), 150–153.
11. [11] Lokugamage, A.U., Sullivan, K.R., Niculescu, I., Tigere, P., Onyangunga, F., Refaey, H.E., et al. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum haemorrhage. Acta Obstet Gynecol Scand 80 (2001), 835–839.
12. [12] Soltan, M.H., Faragallah, M.F., Mosabah, M.H., Al-adawy, A.R., External aortic compression device: the first aid for postpartum haemorrhage control. J Obstet Gynaecol Res 35 (2009), 453–458.
13. [13] Walraven, G., Dampha, Y., Bittaye, B., Sowe, M., Hofmeyr, J., Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial. BJOG: Int J Obstet Gynaecol 111 (2004), 1014–1017.
14. [14] Zuberi, N.F., Durocher, J., Sikander, R., Baber, N., Blum, J., Walraven, G., Misoprostol in addition to routine treatment of postpartum haemorrhage: a hospital-based randomized-controlled trial in Karachi, Pakistan. BMC Pregnancy Childbirth, 8, 2008, 40.
15. [15] Winikoff, B., Dabash, R., Durocher, J., Darwish, E., Ngoc, N.T.N., León, W., et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 375 (2010), 210–216.
16. [16] Blum, J., Winikoff, B., Raghavan, S., Dabash, R., Ramadan, M.C., Dilbaz, B., et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 375 (2010), 217–223.
17. [17] Ducloy-Bouthors, A.-S., Jude, B., Duhamel, A., Broisin, F., Huissoud, C., Keita-Meyer, H., et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care, 15, 2011, R117.
18. [18] Wikkelso, A.J., Edwards, H.M., Afshari, A., Stensballe, J., Langhoff-Roos, J., Albrechtsen, C., et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial. Br J Anaesth 114 (2015), 623–633.
19. [19] Lavigne-Lissalde, G., Aya, A.G., Mercier, F.J., Roger-Christoph, S., Chauleur, C., Morau, E., et al. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum haemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost 13 (2015), 520–529.
20. [20] Deneux-Tharaux, C., Dupont, C., Colin, C., Rabilloud, M., Touzet, S., Lansac, J., et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG: Int J Obstet Gynaecol 117 (2010), 1278–1287.
21. [21] Combs, C.A., Murphy, E.L., Laros, R.K., Factors associated cesarean with haemorrhage in deliveries. Obstet Gynecol Surv 46 (1991), 362–363.
22. [22] Yaju, Y., Kataoka, Y., Eto, H., Horiuchi, S., Mori, R., Prophylactic interventions after delivery of placenta for reducing bleeding during the postnatal period. Cochrane Database Syst Rev(11), 2013, 10.1002/14651858.CD009328.pub2 AN CD009328.
23. [23] Abedi, P., Jahanfar, S., Namvar, F., Nipple stimulation or breastfeeding for preventing postpartum haemorrhage in the third stage of labour. Cochrane Database Syst Rev(11), 2013, 10.1002/14651858.CD010845 AN CD010845.
24. [24] Alfaifel, N., Postpartum haemorrhage: new insights from published trials and the development of novel management options. Ph.D. thesis, 2015, University of Liverpool.
25. [25] WHO, Evaluating the quality of care for severe pregnancy complications: the WHO near-miss approach for maternal health. 2011.
26. [26] Knight, M.W.M., Fitzpatrick, K., Acosta, C., Peirsegaele, P., Mistry, V., Kurinczuk, J.J., UKOSS annual report 2013. 2013.
27. [27] Le Bas, A., Chandraharan, E., Addei, A., Arulkumaran, S., Use of the “obstetric shock index” as an adjunct in identifying significant blood loss in patients with massive postpartum haemorrhage. Int J Gynecol Obstet 124 (2014), 253–255.
28. [28] Cortet, M., Maucort-Boulch, D., Deneux-Tharaux, C., Dupont, C., Rudigoz, R.-C., Roy, P., et al. Severity of post-partum haemorrhage after vaginal delivery is not predictable from clinical variables available at the time post-partum haemorrhage is diagnosed. J Obstet Gynaecol Res 41 (2014), 199–206.
29. [29] Briley, A., Seed, P.T., Tydeman, G., Ballard, H., Waterstone, M., Sandall, J., et al. Reporting errors, incidence and risk factors for postpartum haemorrhage and progression to severe PPH: a prospective observational study. BJOG: Int J Obstet Gynaecol 121 (2014), 876–888.
30. [30] Say, L., Souza, J.P., Pattinson, R.C., Maternal near miss – towards a standard tool for monitoring quality of maternal health care. Best Pract Res Clin Obstet Gynaecol 23 (2009), 287–296.
31. [31] Ambardekar, S., Shochet, T., Bracken, H., Coyaji, K., Winikoff, B., Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trial. BMC Pregnancy Childbirth, 14, 2014, 276.
32. [32] Pacagnella, R.C., Souza, J.P., Durocher, J., Perel, P., Blum, J., Winikoff, B., et al. A systematic review of the relationship between blood loss and clinical signs. PLOS ONE, 8, 2013, e57594.
33. [33] Nathan, H.L., El Ayadi, A., Hezelgrave, N.L., Seed, P., Butrick, E., Miller, S., et al. Shock index: an effective predictor of outcome in postpartum haemorrhage?. BJOG: Int J Obstet Gynaecol 122 (2014), 268–275.
34. [34] Sohn, C.H., Kim, W.Y., Kim, S.R., Seo, D.W., Ryoo, S.M., Lee, Y.S., et al. An increase in initial shock index is associated with the requirement for massive transfusion in emergency department patients with primary postpartum hemorrhage. Shock 40:August (2) (2013), 101–105.
35. [35] International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. http://www.ich.org/home.html [accessed 11.12.15].
36. [36] Council for International Organizations of Medical Sciences. http://www.cioms.ch/ [accessed 12.12.15].
37. [37] Moher, D., Schulz, K.F., Altman, D., Group, C., The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285:15 (2001), 1987–1991.
38. [38] Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D.F., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement, quality of reporting of meta-analyses. Lancet 354:9193 (1999), 1896–1900.
39. [39] Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting, Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.